SCHEMBL24257731

SCHEMBL24257731

Cc1cccc(-c2cnc(C#N)c(Cl)c2C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.42
ADORA1 P30542 3/20 0.42
ADORA2A P29274 2/20 0.42
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 4/20 0.38
HPGD P15428 4/20 0.38
TSHR P16473 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ADORA2B P29275 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30454648 0.89 DHFR (0.44) LRRK2ADORA1ADORA2AALDH1A1KDM4E
SCHEMBL24257698 0.89 DHFR (0.44) LRRK2ADORA1ADORA2AALDH1A1KDM4E
SCHEMBL30453225 0.86 NPSR1 (0.41) ADORA1ADORA2ACYP11B1CYP11B2ALDH1A1
SCHEMBL24257730 0.86 NPSR1 (0.41) ADORA1ADORA2ACYP11B1CYP11B2ALDH1A1
SCHEMBL24257700 0.84 BTK (0.54) LRRK2ADORA1ADORA2AALDH1A1KDM4E
SCHEMBL30453695 0.84 BTK (0.54) LRRK2ADORA1ADORA2AALDH1A1KDM4E
SCHEMBL24257773 0.82 BTK (0.44) ADORA1ADORA2AALDH1A1HPGDSMN1; SMN2
SCHEMBL30546851 0.81 DHFR (0.43) ADORA1ADORA2ACYP11B1CYP11B2ALDH1A1
SCHEMBL24257623 0.81 DHFR (0.43) ADORA1ADORA2ACYP11B1CYP11B2ALDH1A1
SCHEMBL24257695 0.80 KDM4E (0.45) CYP11B1CYP11B2ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022036188-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE AKEBIA THERAPEUTICS, INC. (US) 2022-02-17 WO disclosed